"Schlesinger Group is a global marketing research supplier offering qualitative and quantitative data collection, in-person, on the phone, or online."

During the past decade, Schlesinger Chicago conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Schlesinger Chicago" are "Smoking" (2 trials), "Tobacco Smoking" (2 trials) and "Tobacco Use" (2 trials). Many other conditions were trialed in "Schlesinger Chicago" in a lesser frequency.

Most popular intervention types in "Schlesinger Chicago" are "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "40007385" (1 trials), "40007386" (1 trials), "40007387" (1 trials), "40007388" (1 trials) and "P1012818 nicotine pouch" (1 trials). Other intervention names were less common.

The vast majority of trials in "Schlesinger Chicago" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Schlesinger Chicago". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Schlesinger Chicago, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Schlesinger Chicago, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".